Clinical Trial Update: Letrozole in the Treatment of Severe and Recurrent Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating letrozole for the treatment of severe and recurrent endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Letrozole ( Femara ) (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Severe and Recurrent Endometriosis | Phase 2 | Status: COMPLETED